Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

1.

MicroRNAs play a big role in regulating ovarian cancer-associated fibroblasts and the tumor microenvironment.

Chou J, Werb Z.

Cancer Discov. 2012 Dec;2(12):1078-80. doi: 10.1158/2159-8290.CD-12-0465.

PMID:
23230184
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer.

Mitra AK, Zillhardt M, Hua Y, Tiwari P, Murmann AE, Peter ME, Lengyel E.

Cancer Discov. 2012 Dec;2(12):1100-8. doi: 10.1158/2159-8290.CD-12-0206. Epub 2012 Nov 21.

PMID:
23171795
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis.

Yang G, Rosen DG, Zhang Z, Bast RC Jr, Mills GB, Colacino JA, Mercado-Uribe I, Liu J.

Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16472-7. Epub 2006 Oct 23.

PMID:
17060621
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.

Taylor DD, Gercel-Taylor C.

Gynecol Oncol. 2008 Jul;110(1):13-21. doi: 10.1016/j.ygyno.2008.04.033. Erratum in: Gynecol Oncol. 2010 Jan;116(1):153.

PMID:
18589210
[PubMed - indexed for MEDLINE]
5.

Interleukin-1β promotes ovarian tumorigenesis through a p53/NF-κB-mediated inflammatory response in stromal fibroblasts.

Schauer IG, Zhang J, Xing Z, Guo X, Mercado-Uribe I, Sood AK, Huang P, Liu J.

Neoplasia. 2013 Apr;15(4):409-20.

PMID:
23555186
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.

Chao A, Lin CY, Lee YS, Tsai CL, Wei PC, Hsueh S, Wu TI, Tsai CN, Wang CJ, Chao AS, Wang TH, Lai CH.

Oncogene. 2012 Feb 9;31(6):764-75. doi: 10.1038/onc.2011.269. Epub 2011 Jul 4.

PMID:
21725366
[PubMed - indexed for MEDLINE]
7.

miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response.

Mateescu B, Batista L, Cardon M, Gruosso T, de Feraudy Y, Mariani O, Nicolas A, Meyniel JP, Cottu P, Sastre-Garau X, Mechta-Grigoriou F.

Nat Med. 2011 Nov 20;17(12):1627-35. doi: 10.1038/nm.2512.

PMID:
22101765
[PubMed - indexed for MEDLINE]
8.

MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.

Cheng W, Liu T, Wan X, Gao Y, Wang H.

FEBS J. 2012 Jun;279(11):2047-59. doi: 10.1111/j.1742-4658.2012.08589.x. Epub 2012 Apr 24.

PMID:
22498306
[PubMed - indexed for MEDLINE]
9.

MicroRNAs in ovarian carcinomas.

Dahiya N, Morin PJ.

Endocr Relat Cancer. 2010 Jan 29;17(1):F77-89. doi: 10.1677/ERC-09-0203. Print 2010 Mar. Review.

PMID:
19903743
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Pleiotropic actions of miR-21 highlight the critical role of deregulated stromal microRNAs during colorectal cancer progression.

Bullock MD, Pickard KM, Nielsen BS, Sayan AE, Jenei V, Mellone M, Mitter R, Primrose JN, Thomas GJ, Packham GK, Mirnezami AH.

Cell Death Dis. 2013 Jun 20;4:e684. doi: 10.1038/cddis.2013.213. Erratum in: Cell Death Dis. 2013;4:e748. Mirenzami, AH [corrected to Mirnezami, AH].

PMID:
23788041
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer.

Musumeci M, Coppola V, Addario A, Patrizii M, Maugeri-Saccà M, Memeo L, Colarossi C, Francescangeli F, Biffoni M, Collura D, Giacobbe A, D'Urso L, Falchi M, Venneri MA, Muto G, De Maria R, Bonci D.

Oncogene. 2011 Oct 13;30(41):4231-42. doi: 10.1038/onc.2011.140. Epub 2011 May 2.

PMID:
21532615
[PubMed - indexed for MEDLINE]
12.

MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis.

Kadera BE, Li L, Toste PA, Wu N, Adams C, Dawson DW, Donahue TR.

PLoS One. 2013 Aug 22;8(8):e71978. doi: 10.1371/journal.pone.0071978. eCollection 2013.

PMID:
23991015
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.

Hu X, Macdonald DM, Huettner PC, Feng Z, El Naqa IM, Schwarz JK, Mutch DG, Grigsby PW, Powell SN, Wang X.

Gynecol Oncol. 2009 Sep;114(3):457-64. doi: 10.1016/j.ygyno.2009.05.022. Epub 2009 Jun 5.

PMID:
19501389
[PubMed - indexed for MEDLINE]
14.

MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.

Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY.

Cancer Res. 2007 Sep 15;67(18):8433-8. Epub 2007 Sep 6.

PMID:
17823410
[PubMed - indexed for MEDLINE]
Free Article
15.

Cancer associated fibroblasts express pro-inflammatory factors in human breast and ovarian tumors.

Erez N, Glanz S, Raz Y, Avivi C, Barshack I.

Biochem Biophys Res Commun. 2013 Aug 2;437(3):397-402. doi: 10.1016/j.bbrc.2013.06.089. Epub 2013 Jul 2.

PMID:
23831470
[PubMed - indexed for MEDLINE]
16.

MicroRNA signatures in human ovarian cancer.

Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, Calin GA, Ménard S, Croce CM.

Cancer Res. 2007 Sep 15;67(18):8699-707.

PMID:
17875710
[PubMed - indexed for MEDLINE]
Free Article
17.

MicroRNAs in ovarian cancer biology and therapy resistance.

van Jaarsveld MT, Helleman J, Berns EM, Wiemer EA.

Int J Biochem Cell Biol. 2010 Aug;42(8):1282-90. doi: 10.1016/j.biocel.2010.01.014. Epub 2010 Jan 18. Review.

PMID:
20083225
[PubMed - indexed for MEDLINE]
18.

MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis.

Singh B, Ronghe AM, Chatterjee A, Bhat NK, Bhat HK.

Carcinogenesis. 2013 May;34(5):1165-72. doi: 10.1093/carcin/bgt026. Epub 2013 Mar 14.

PMID:
23492819
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

MicroRNA expression and regulation in human ovarian carcinoma cells by luteinizing hormone.

Cui J, Eldredge JB, Xu Y, Puett D.

PLoS One. 2011;6(7):e21730. doi: 10.1371/journal.pone.0021730. Epub 2011 Jul 12.

PMID:
21765906
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1.

Guo LM, Pu Y, Han Z, Liu T, Li YX, Liu M, Li X, Tang H.

FEBS J. 2009 Oct;276(19):5537-46. doi: 10.1111/j.1742-4658.2009.07237.x. Epub 2009 Aug 21.

PMID:
19702828
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk